Yervoy (Ipilimumab)

Yervoy (Ipilimumab) is a cancer immunotherapy medication that helps the body’s immune system recognize and attack cancer cells. It works by blocking a protein called CTLA-4, which normally dampens immune responses. By inhibiting this protein, Yervoy enhances the immune system’s ability to target and destroy tumors, particularly in cancers like melanoma. It is administered through intravenous infusion and is used primarily for advanced or metastatic cancers. While effective, it can also cause immune-related side effects, so it is closely monitored by healthcare providers.